Testing effectiveness (Phase 2)Study completedNCT05228470What this trial is testingElranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.Who this might be right forElranatamabMyelomaMultiple Myeloma+8 more Pfizer 39